Table 1.
Patient characteristics
| Total (n = 162) | PCI (n = 93) | No PCI (n = 69) | P value | |
|---|---|---|---|---|
| Age | ||||
| Median(range) | 67.5 (23–85) | 65 (23–76) | 72 (28–85) | <0.001 |
| Gender | ||||
| Male | 130 (80%) | 74 (80%) | 56 (81%) | 0.802 |
| Female | 32 (20%) | 19 (20%) | 13 (19%) | |
| ECOG PS | ||||
| 0 | 71 (44%) | 40 (43%) | 31 (45%) | 0.808 |
| 1 or 2 | 91 (56%) | 53 (57%) | 38 (55%) | |
| Stage | ||||
| IIA | 13 (8%) | 13 (14%) | 10 (14%) | 0.926 |
| IIB | 10 (6%) | |||
| IIIA | 63 (39%) | 80 (86%) | 59 (86%) | |
| IIIB | 76 (47%) | |||
| Radiation dose | ||||
| 45 Gy AHF | 94 (58%) | 68 (73%) | 26 (38%) | <0.001 |
| 50 Gy CF | 68 (42%) | 25 (27%) | 43 (62%) | |
| SER | ||||
| ≥30 days | 95 (59%) | 43 (46%) | 52 (75%) | <0.001 |
Bold values mean statistical significance (P value <0.05).
ECOG PS = Eastern Cooperative Oncology Group Performance Status, SER = start of any treatment until the end of chest irradiation, AHF = accelerated hyperfractionated radiotherapy, CF = conventional fractionated radiotherapy, PCI = prophylactic cranial irradiation.